P. K. Sharkey - Concepedia

Concepedia

Author

P. K. Sharkey

The University of Texas Health Science Center at San Antonio

Also Known As

P K Sharkey, P. K. Sharkey, P.K. Sharkey, Patricia K. Sharkey, Patricia Kay Sharkey, Patricia Sharkey

16

Publications

2.2K

Citations

10

H-Index

30

Concepts

All Affiliations

The University of Texas Health Science Center at San Antonio Murphy Oil Corporation (United States)Santa Clara Valley Medical Center Stanford University California Institute for Medical Research

PK

About

P. K. Sharkey is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, antifungal agents, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.5K
2	Health Sciences	3	3	865
3	Immunology	2	2	355
4	Biology	1	1	45
5	Hospital Medicine	1	1	484

P. K. Sharkey

×

11

Publications

2.2K

Citations

10

H-Index

	Year	Citations
Comparison of Amphotericin B with Fluconazole in the Treatment of Acute AIDS-Associated Cryptococcal Meningitis Michael S. Saag, William G. Powderly, Gretchen A. Cloud, New England Journal of Medicine	1992	633
Prospective Multicenter Surveillance Study of Funguria in Hospitalized Patients Carol A. Kauffman, Jack D. Sobel, H A Gallis, Clinical Infectious Diseases UrologyAntifungal AgentHospital MedicineAntibioticsUrinary Tract Abnormalities	2000	484
Itraconazole treatment of phaeohyphomycosis P. K. Sharkey, John R. Graybill, Michael G. Rinaldi, Journal of the American Academy of Dermatology Diagnostic MycologyAntifungal AgentAntifungal AgentsClinical MycologyDermatology	1990	212
Amphotericin B Lipid Complex Compared with Amphotericin B in the Treatment of Cryptococcal Meningitis in Patients with AIDS P. K. Sharkey, John R. Graybill, E S Johnson, Clinical Infectious Diseases ImmunologyAntimicrobial ChemotherapyStudy ObjectiveHematologySepsis	1996	198
Interaction of Azoles with Rifampin, Phenytoin, and Carbamazepine: In Vitro and Clinical Observations Richard Tucker, David W. Denning, L H Hanson, Clinical Infectious Diseases Clinical ObservationsPharmacotherapyAntimicrobial ChemotherapyDermatologyExperimental Pharmacology	1992	183
Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients John J. Stern, Barry J. Hartman, P. K. Sharkey, The American Journal of Medicine Primary ImmunodeficiencyAcquired Immunodeficiency SyndromeImmunodeficienciesImmunologyOral Fluconazole Therapy	1988	157
High-dose itraconazole in the treatment of severe mycoses P. K. Sharkey, Michael G. Rinaldi, James F. Dunn, Antimicrobial Agents and Chemotherapy Progressive InfectionSevere Systemic MycosesAntifungal AgentsSystemic MycosesClinical Mycology	1991	153
Fluconazole Therapy for Histoplasmosis D. S. McKinsey, Carol A. Kauffman, Peter G. Pappas, Clinical Infectious Diseases Parasitic ProtozoaAntifungal Agents200-800 MgHistopathologyRespiratory Infection	1996	85
Bipolaris hawaiiensis-caused Phaeohyphomycotic Orbitopathy Steven L. Maskin, Richard J. Fetchick, Charles R. Leone, Ophthalmology BiologyPhytoplasmas	1989	45
Fungal infections and their management. John R. Graybill, P. K. Sharkey PubMed Medicinal ChemistryAntifungal AgentAntifungal AgentsPharmacologyFungal Infections	1990	17

Page 1